Hostname: page-component-586b7cd67f-rcrh6 Total loading time: 0 Render date: 2024-11-26T13:07:50.907Z Has data issue: false hasContentIssue false
  • English
  • Français

Outcome of patent ductus arteriosus ligation in premature infants in the East of England: a prospective cohort study

Published online by Cambridge University Press:  20 November 2012

Sok-Leng Kang ,
Salehuddin Samsudin ,
Minju Kuruvilla ,
Anshoo Dhelaria ,
Sue Kent  and
Wilfred A. Kelsall
Sok-Leng Kang
Affiliation:
Paediatric Cardiology, University Hospital of Wales, Cardiff, United Kingdom
Salehuddin Samsudin
Affiliation:
Neonatal Intensive Care Unit, Royal Preston Hospital, Preston, United Kingdom
Minju Kuruvilla
Affiliation:
Neonatal Intensive Care Unit, Saint Mary's Hospital, Central Manchester University Hospitals, Manchester, United Kingdom
Anshoo Dhelaria
Affiliation:
Paediatric Department, East and North Hertfordshire Hospital, Stevenage, United Kingdom
Sue Kent
Affiliation:
Neonatal Intensive Care Unit, Addenbrookes Hospital, Cambridge University Foundation Trust, Cambridge, United Kingdom
Wilfred A. Kelsall*
Affiliation:
Neonatal Intensive Care Unit, Addenbrookes Hospital, Cambridge University Foundation Trust, Cambridge, United Kingdom
*
Correspondence to: Dr W. A. Kelsall, BSc, MB, BChir, FRCPCH, Neonatal Intensive Care Unit, Box 226, Addenbrookes Hospital, Hills Road, Cambridge CB2 2QQ, United Kingdom. Tel: +01223256941; Fax: +01223217064; E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Background

Surgical ligation of patent ductus arteriosus is considered when medical treatment fails or is contraindicated. This study aims to determine the mortality and morbidity of preterm neonates referred for patent ductus arteriosus ligation.

Methods

A prospective study was conducted in the East of England to follow the outcome of premature infants under 37 weeks’ gestation undergoing patent ductus arteriosus ligation. A standardised proforma was used to collect information before and after the procedure.

Results

A total of 102 premature infants were recruited, and patent ductus arteriosus ligation was performed in 92. Surgical complications occurred in 8.7% (8/92), which included pneumothorax (5/8), recurrent laryngeal nerve palsy (2/8), and chylothorax (1/8). Morbidity outcome data were not available for all infants. The incidence of chronic lung disease was 88% (88/99); intraventricular haemorrhage was 49% (49/100); necrotising enterocolitis 39% (39/99), and retinopathy of prematurity 42% (41/97). The overall mortality rate in our study was 7.8% (8/102). Mortality rate in infants who had patent ductus arteriosus ligation was 4.3% (4/92). The 30-day survival rate after ligation was 99% (91/92). Beyond 30 days post-ligation, three infants died from other causes that were not directly related to surgery.

Conclusion

Patent ductus arteriosus ligation in premature infants is associated with low mortality and complication rates; however, there is a high incidence of neonatal morbidity. Surgical capacity for patent ductus arteriosus ligation needs to be carefully planned nationally as the duration of “waiting time” and transport to another surgical centre could adversely affect outcomes in this high-risk population.

Keywords

Patent ductus arteriosusligationneonatemortalitymorbidity
Type
Original Articles
Information
Cardiology in the Young , Volume 23 , Issue 5 , October 2013 , pp. 711 - 716
Copyright
Copyright © Cambridge University Press 2012 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Clyman, RI, Mauray, F, Heymann, MA, Roman, C. Cardiovascular effects of patent ductus arteriosus in preterm lambs with respiratory distress. J Pediatr 1987; 111: 579–587.CrossRefGoogle ScholarPubMed
2. Alpan, G, Scheerer, R, Bland, R, Clyman, R. Patent ductus arteriosus increases lung fluid filtration in preterm lambs. Pediatr Res 1991; 30: 616–621.Google Scholar
3. Lemmers, PM, Toet, MC, van Bel, F. Impact of patent ductus arteriosus and subsequent therapy with indomethacin on cerebral oxygenation in preterm infants. Pediatrics 2008; 121: 142–147.Google Scholar
4. Noori, S, McCoy, M, Friedlich, P, et al. Failure of ductus arteriosus closure is associated with increased mortality in preterm infants. Pediatrics 2009; 123: e138–e144.Google Scholar
5. Bancalari, E. Changes in the pathogenesis and prevention of chronic lung disease of prematurity. Am J Perinatol 2001; 18: 1–9.CrossRefGoogle ScholarPubMed
6. Bancalari, E, Claure, N, Gonzalez, A. Patent ductus arteriosus and respiratory outcome in premature infants. Biol Neonate 2005; 88: 192–201.Google Scholar
7. Kluckow, M, Evans, N. Ductal shunting, high pulmonary blood flow, and pulmonary hemorrhage. J Pediatr 2000; 137: 68–72.Google Scholar
8. Ryder, RW, Shelton, JD, Guinan, ME. Necrotizing enterocolitis: a prospective multicenter investigation. Am J Epidemiol 1980; 112: 113–123.Google Scholar
9. Dollberg, S, Lusky, A, Reichman, B. Patent ductus arteriosus, indomethacin and necrotizing enterocolitis in very low birthweight infants: a population-based study. J Pediatr Gastroenterol Nutr 2005; 40: 184–188.Google Scholar
10. Evans, N, Kluckow, M. Early ductal shunting and intraventricular haemorrhage in ventilated preterm infants. Arch Dis Child Fetal Neonatal Ed 1996; 75: F183–F186.Google Scholar
11. Noori, S, McCoy, M, Friedlich, P, et al. Failure of ductus arteriosus closure is associated with increased mortality in preterm infants. Pediatrics 2009; 123: e138–e144.CrossRefGoogle ScholarPubMed
12. Schmidt, B, Davis, P, Moddemann, D, et al. Long-term effects of indomethacin prophylaxis in extremely low-birth-weight infants. N Engl J Med 2001; 344: 1966–1972.Google Scholar
13. Gournay, V, Roze, JC, Kuster, A, et al. Prophylactic ibuprofen versus placebo in very premature infants: a randomized, double blind, placebo-controlled trial. Lancet 2004; 364: 1939–1944.Google Scholar
14. Ohlsson, A, Shah, SS. Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database Syst Rev 2011, issue 7, CD004213.Google Scholar
15. Herrera, C, Holberton, J, Davis, P. Prolonged versus short course of indomethacin for the treatment of patent ductus arteriosus in preterm infants. Cochrane Database Syst Rev 2007, issue 2, CD003480.CrossRefGoogle Scholar
16. Kaapa, P, Lanning, P, Koivisto, M. Early closure of patent ductus arteriosus with indomethacin in preterm infants with idiopathic respiratory distress syndrome. Acta Paediatr Scand 1983; 72: 179–184.Google Scholar
17. Cotton, RB, Stahlman, MT, Berder, HW, Graham, TP, Catterton, WZ, Kover, I. Randomized trial of early closure of symptomatic patent ductus arteriosus in small preterm infants. J Pediatr 1978; 93: 647–651.Google Scholar
18. Clyman, R, Cassady, G, Kirklin, JK, et al. The role of patent ductus arteriosus ligation in bronchopulmonary dysplasia: re-examining a randomized controlled trial. J Pediatr 2009; 154: 873–876.CrossRefGoogle Scholar
19. Chorne, N, Leonard, C, Piecuch, R, et al. Patent ductus arteriosus and its treatment as risk factors for neonatal and neurodevelopmental morbidity. Pediatrics 2007; 119: 1165–1174.CrossRefGoogle ScholarPubMed
20. Malviya, M, Ohlsson, A, Shah, S. Surgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infants. Cochrane Database Syst Rev 2008, issue 1, CD003951.Google Scholar
21. Madan, JC, Kendrick, D, Hagadorn, JI, et al. Patent ductus arteriosus therapy: impact on neonatal and 18 month outcome. Pediatrics 2009; 123: 674–681.Google Scholar
22. Kabra, NS, Schmidt, B, Roberts, RS, et al. Neurosensory impairment after surgical closure of patent ductus arteriosus in extremely low birthweight infants: results from the Trial of Indomethacin Prophylaxis in Preterms. J Pediatr 2007; 150: 229–234.Google Scholar
23. Mandhan, P, Brown, S, Kukkady, A, et al. Surgical closure of patent ductus arteriosus in preterm low birth weight infants. Congenit Heart Dis 2009; 4: 34–37.Google Scholar
24. Lee, LC, Tillett, A, Tulloh, R, et al. Outcome following patent ductus arteriosus ligation in premature infants: a retrospective cohort analysis. BMC Paediatr 2006; 6: 15–20.CrossRefGoogle ScholarPubMed
25. Heuchan, AM, Hunter, L, Young, D, et al. Outcomes following the surgical ligation of the patent ductus arteriosus in premature infants in Scotland. Arch Dis Child Fetal Neonatal Ed 2012; 97: 39–44.Google Scholar
26. https://nicor4.nicor.org.uk/CHD/an_paeds.nsf/WBenchmarksYears?openview&RestrictToCategory=2009&start=1&count=500 (accessed September 2012).Google Scholar
27. Malone, PS, Roberts, KD, Abrams, LD, et al. Day-case ligation of patent ductus arteriosus in premature infants. J Pediatr Surg 1987; 22: 284–285.Google Scholar
28. Costeleo, K, Hennessey, E, Myles, J. Draper E for the EPICure Group. EPICure 2: Survival and early morbidity of extremely preterm babies in England: changes since 1995. Arch Dis Child 2008; 93 (Suppl 1); A33 (Abstract).Google Scholar
29. Gould, DS, Montenegro, LM, Gaynor, JW, et al. A comparison of on-site and off-site patent ductus arteriosus ligation in premature infants. Pediatrics 2003; 112: 1298–1301.Google Scholar
30. Francis, E, Singhi, AK, Lakshmivenkateshaiah, S, Kumar, RK. Transcatheter occlusion of patent ductus arteriosus in preterm infants. J Am Coll Cardiol Intv 2010; 3: 550–555.Google Scholar
31. Betham, J, Meur, S, Hudsmith, L, Archer, N, Wilson, N. Echocardiographically guided catheter closure of arterial ducts in small preterm infants on the neonatal intensive care unit. Catheter Cardiovasc Interv 2011; 77: 409–415.Google Scholar
32. Baraldi, E, Filippone, M. Chronic lung disease after premature birth. N Engl J Med 2007; 357: 1946–1955.Google Scholar
33. Wheeler, K, Klingenberg, C, McCallion, N, et al. Volume-targeted versus pressure-limited ventilation in the neonate. Cochrane Database Syst Rev 2010, issue 11, CD003666.Google ScholarPubMed
34. Loh, M, Osborn, DA, Lui, K. Outcome of very premature infants with necrotising enterocolitis cared for in centres with or without on site surgical facilities. Arch Dis Child Fetal Neonatal Ed 2001; 85: F114–F118.CrossRefGoogle ScholarPubMed
35. Trus, T, Winthrop, AL, Pipe, S. Optimal management of patent ductus arteriosus in the neonate weighing less than 800 g. J Pediatr Surg 1993; 28: 1137–1139.Google Scholar
36. Koehne, PS, Bein, G, Alexi-Meskhishvili, V, et al. Patent ductus arteriosus in very low birthweight infants: complication of pharmacological and surgical treatment. J Perinat Med 2001; 29: 327–334.Google Scholar
37. Palder, SB, Schwartz, MZ, Tyson, KR, et al. Management of patent ductus arteriosus: a comparison of operative versus pharmacologic treatment. J Paediatr Surg 1987; 22: 1171–1174.Google Scholar
38. Cassady, G, Crouse, DT, Kirklin, JW, et al. A randomised controlled trial of very early prophylactic ligation of the ductus arteriosus in babies who weighed 1000 g or less at birth. N Engl J Med 1989; 320: 1511–1516.Google Scholar
39. Jhaveri, N, Moon-Grady, A, Clyman, RI. Early surgical ligation versus a conservative approach for management of patent ductus arteriosus that fails to close after indomethacin treatment. J Pediatr 2010; 157: 381–387.Google Scholar